A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in a Healthy Pediatric Population in the USA



Status:Completed
Conditions:Influenza
Therapuetic Areas:Immunology / Infectious Diseases
Healthy:No
Age Range:Any - 9
Updated:5/25/2018
Start Date:August 2009
End Date:April 2010

Use our guide to learn which trials are right for you!

A Phase II, Multicenter, Randomized, Observer-Blind, Placebo-Controlled Study to Evaluate the Immunogenicity, Safety and Tolerability of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in a Healthy Pediatric Population

The purpose of this study is to evaluate the immunogenicity and safety profile of CSL425
(CSL's 2009 H1N1 influenza vaccine) in a healthy pediatric population.


Inclusion Criteria:

- Male or female aged >= 6 months to < 9 years at the time of the first study
vaccination.

- For children < 3 years of age at the time of first vaccination, born at or after 36
weeks gestation.

Exclusion Criteria:

- Known hypersensitivity to a previous dose of influenza virus vaccine or allergy to
eggs, chicken protein, neomycin, polymyxin, or any components of the Study Vaccine
We found this trial at
13
sites
726
mi
from
Cincinnati, OH
Click here to add this to my saved trials
522
mi
from
Austin, TX
Click here to add this to my saved trials
937
mi
from
Austintown, OH
Click here to add this to my saved trials
673
mi
from
Bardstown, KY
Click here to add this to my saved trials
845
mi
from
Chandler, AZ
Click here to add this to my saved trials
346
mi
from
Fort Worth, TX
Click here to add this to my saved trials
569
mi
from
Houston, TX
Click here to add this to my saved trials
1003
mi
from
Latrobe, PA
Click here to add this to my saved trials
1198
mi
from
Melbourne, FL
Click here to add this to my saved trials
690
mi
from
Metairie, LA
Click here to add this to my saved trials
778
mi
from
Murray, UT
Click here to add this to my saved trials
262
mi
from
Omaha, NE
Click here to add this to my saved trials
971
mi
from
Pittsburgh, PA
Click here to add this to my saved trials